Clin2
NCT04762082Worth exploringNot yet recruiting

Test gummy tadalafil to see how the body absorbs it

Erectile Dysfunction

Treatments studied

Part of Kidney & urinary, Mental health clinical trials.

This Phase 1 study tests how different tadalafil gummy-style products move through your body after a single dose. It’s done in healthy adult volunteers and helps scientists understand dosing and absorption safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
19 years to 65 years
Study type
Interventional

Who can take part

  • Be a man age 19–65 and able to attend all study visits
  • Be willing to sign consent and allow multiple blood draws and storage
  • Do not use any erectile dysfunction or prostate medicine during the study (including PDE5 inhibitors and LUTS treatments)
  • For a set time before the study, avoid certain medicines and substances that can interact with tadalafil (like nitrates, some blood pressure medicines, and some enzyme-changing drugs)
  • Have an acceptable prostate screening result (acceptable PSA score or a negative prostate biopsy within 12 months)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07117383Not yet recruiting· Phase 1
Comparing sildenafil products in healthy men

This trial tests how different forms of sildenafil (the active ingredient in Viagra) are absorbed by the body after a high-fat meal. It is for healthy men to help ensure the products work the same way.

New York, New York
NCT07753720Recruiting· Phase 4
Daily tadalafil with or without another treatment for erectile dysfunction

This study tests whether taking tadalafil daily, either alone or with a second treatment, works better for men with erectile dysfunction who have not responded to on-demand pills. It aims to help men who have not had success with current treatments.

Cairo
NCT05052879Not yet recruiting· Phase 3
Test a treatment for erectile problems and early ejaculation

This Phase 3 study tests how well a Toronto Association treatment works for men who have both erectile dysfunction and premature ejaculation, while also checking safety. You may be able to join if your symptoms match the study targets and you can stay on a steady, stable sexual routine and relationship during the study.

NCT07642505Recruiting· Phase 4
L-Citrulline and Tadalafil for Mild Erectile Dysfunction

This study tests whether two compounds—L-citrulline (a natural amino acid) and tadalafil (a common erectile dysfunction medication)—work well together for men with mild to moderate erectile problems. The goal is to see if this combination safely improves sexual function.

Banī Suwayf, Beni Suweif Governorate
NCT05955001Recruiting· Phase 2/Phase 3
Tadalafil for early urinary symptoms after prostate surgery

This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.

Al Mansurah, Dakahlia Governorate
NCT06264414Not yet recruiting· Phase 3
New treatment for erectile dysfunction with enlarged prostate

This trial tests a new drug, DTT106, for men who have both erectile dysfunction and an enlarged prostate (BPH). It is for men already taking dutasteride and tamsulosin and aims to see if the new treatment improves erections better.

Hortolândia, São Paulo

Hear when a new Erectile Dysfunction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.